Delivery Order SPE2DB20D9331-SPE2DB21FL1J7

Award Date 6/21/21
Potential Completion Date 6/22/21
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of various pharmaceutical products and medical supplies. The contract has a ceiling value of $1,304.67 and a completion date of May 22, 2024. This order was issued under DMS Pharmaceutical's existing indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which supports the recurring medical supply needs of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies. This order, valued at $2,319.51, is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999. The IDC, under the DLA's SPE2DB program, allows the agency to issue delivery orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies to support military health facilities. The contract has a ceiling value of $1,381.20 and runs through June 28, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA's...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued up to $1,543.92, covers the delivery of various medications including branded and generic prescription drugs, over-the-counter products, biologics, and...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at up to $21,322.56, has an ultimate completion date of August 31, 2023. DMS Pharmaceutical Group is an established supplier of branded and generic prescription drugs,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies for military health facilities. The contract has a ceiling value of $80,218.40 and runs through June 10, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA, valued up to $499,999,999, that allows the agency to issue delivery orders...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the medical needs of military health facilities worldwide. The contract, valued at up to $12,508.75, covers the delivery of various medications and medical consumables, including branded and generic prescription drugs, over-the-counter...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $1,481.80, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The delivery order, which is part of the DLA's Medical Supply Chain division SPE2DB program, is for the supply of pharmaceutical products, including prescription drugs, over-the-counter medications, and medical consumables, to support the recurring medical supply needs of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including prescription drugs, over-the-counter medications, and medical consumables. The contract, valued at up to $1,412.68, supports the recurring medical supply needs of military health facilities worldwide. This award is part of a larger indefinite delivery contract (IDC)...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB21FL1J7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at $1,221.12, is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive array of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing critical and routine medications to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 1/9/25, 9:35 AM